title: Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall.
abstract: The taurine amino-acid derivative, taurolidine, bis-(1,1-dioxoperhydro-1,2,4-thiabiazinyl-4)methane, shows broad antibacterial action against gram-positive and gram-negative bacteria, mycobacteria and some clinically relevant fungi. It inhibits, in vitro, the adherence of Escherichia coli and Staphylococcus aureus to human epithelial and fibroblast cells. Taurolidine is unstable in aqueous solution and breaks down into derivatives which are thought to be responsible for the biological activity. To understand the taurolidine antibacterial mechanism of action, we provide the experimental single crystal X-ray diffraction results together with theoretical methods to characterize the hydrolysis/decomposition reactions of taurolidine. The crystal structure features two independent molecules linked through intermolecular H-bonds with one of them somewhat positively charged. Taurolidine in a biological environment exists in equilibrium with taurultam derivatives and this is described theoretically as a 2-step process without an energy barrier: formation of cationic taurolidine followed by a nucleophilic attack of O(hydroxyl) on the exocyclic C(methylene). A concerted mechanism describes the further hydrolysis of the taurolidine derivative methylol-taurultam. The interaction of methylol-taurultam with the diaminopimelic NH(2) group in the E. coli bacteria cell wall (peptidoglycan) has a negative DeltaG value (-38.2 kcal/mol) but a high energy barrier (45.8 kcal/mol) suggesting no reactivity. On the contrary, taurolidine docking into E. coli fimbriae protein, responsible for bacteria adhesion to the bladder epithelium, shows it has higher affinity than mannose (the natural substrate), whereas methylol-taurultam and taurultam are less tightly bound. Since taurolidine is readily available because it is administered in high doses after peritonitis surgery, it may successfully compete with mannose explaining its effectiveness against bacterial infections at laparoscopic lesions.
authors.affiliation: Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Rome, Italy. caruso@vassar.edu
authors.forename: Francesco
authors.initials: F
authors.lastname: Caruso
authors.forename: James W
authors.initials: JW
authors.lastname: Darnowski
authors.forename: Cristian
authors.initials: C
authors.lastname: Opazo
authors.forename: Alexander
authors.initials: A
authors.lastname: Goldberg
authors.forename: Nina
authors.initials: N
authors.lastname: Kishore
authors.forename: Elin S
authors.initials: ES
authors.lastname: Agoston
authors.forename: Miriam
authors.initials: M
authors.lastname: Rossi
mesh_terms: D001422:Bacterial Adhesion / Q000187:drug effects*; D002473:Cell Wall / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects*; D008958:Models, Molecular; D013654:Taurine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D013829:Thiadiazines / Q000737:chemistry / Q000494:pharmacology*; D014169:Transformation, Bacterial
chemical_list: D013829:Thiadiazines; D013654:Taurine; C012566:taurolidine